Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune system activation via viral infection of tumor cells refers to the process by which viruses—either naturally occurring or genetically engineered (oncolytic viruses)—infect and replicate within cancer cells, leading to both direct tumor cell lysis and the stimulation of robust anti-tumor immune responses. This approach leverages the body's natural antiviral defense mechanisms to recognize, attack, and eliminate malignant cells.
Viral infection → oncolysis → release/presentation TAAs/DAMPs → innate/adaptive immunity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Activation via Viral Infection of Tumor Cells.